Cargando…

Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma

SIMPLE SUMMARY: Multiple gene expression signatures with biological or prognostic subgroups have been published in diffuse large B-cell lymphoma (DLBCL). With exception of the cell of origin (COO) classifier, these were not validated in independent cohorts. The aim of the study was to reproduce four...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plaça, Jessica Rodrigues, Diepstra, Arjan, Los, Tjitske, Mendeville, Matías, Seitz, Annika, Lugtenburg, Pieternella J., Zijlstra, Josée, Lam, King, da Silva, Wilson Araújo, Ylstra, Bauke, de Jong, Daphne, van den Berg, Anke, Nijland, Marcel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909016/ https://www.ncbi.nlm.nih.gov/pubmed/35267654 http://dx.doi.org/10.3390/cancers14051346

Ejemplares similares

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice
por: Mendeville, Matias, et al.
Publicado: (2022)

A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma
por: Mendeville, Matias, et al.
Publicado: (2022)

Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study
por: Kersten, Marie José, et al.
Publicado: (2020)

Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
por: Zwezerijnen, Gerben J. C., et al.
Publicado: (2022)

Tumour necrosis as assessed with (18)F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
por: Kahle, Xaver U., et al.
Publicado: (2019)

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma
por: Nijland, Marcel, et al.
Publicado: (2018)

Primary therapy and survival among patients with nodular lymphocyte‐predominant Hodgkin lymphoma: a population‐based analysis in the Netherlands, 1993–2016
por: Posthuma, Hidde L. A., et al.
Publicado: (2019)

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
por: Posthuma, Hidde L. A., et al.
Publicado: (2021)

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?
por: Nijland, Marcel, et al.
Publicado: (2017)

Interaction between ERAP Alleles and HLA Class I Types Support a Role of Antigen Presentation in Hodgkin Lymphoma Development
por: Jiang, Peijia, et al.
Publicado: (2021)

Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018
por: Durmaz, Müjde, et al.
Publicado: (2022)

Interim thymus and activation regulated chemokine versus interim (18)F‐fluorodeoxyglucose positron‐emission tomography in classical Hodgkin lymphoma response evaluation
por: Plattel, Wouter J., et al.
Publicado: (2020)

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter phase II HOVON trial
por: Chamuleau, Martine E.D., et al.
Publicado: (2019)

Marie Curie – Genome Architecture in Relation to Disease
por: Ylstra, Bauke
Publicado: (2007)

P031: CD4+ T cells in close proximity to Hodgkin-Reed Sternberg cells are antigen experienced, polyclonal and display an exhausted phenotype
por: Veldman, Johanna, et al.
Publicado: (2022)

Intensity-based analysis of dual-color gene expression data as an alternative to ratio-based analysis to enhance reproducibility
por: Bossers, Koen, et al.
Publicado: (2010)

P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
por: Maas, Carolien, et al.
Publicado: (2023)

Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren’s Syndrome
por: Bult, Johanna A. A., et al.
Publicado: (2022)

CD57+ T-cells are a subpopulation of T-follicular helper cells in nodular lymphocyte predominant Hodgkin lymphoma
por: Sattarzadeh, Ahmad, et al.
Publicado: (2015)

Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma
por: Visser, Lydia, et al.
Publicado: (2016)

Erratum: Lydia Visser et al. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma, Int. J. Mol. Sci. 2016, 17, 2127
por: Sattarzadeh, Ahmad, et al.
Publicado: (2018)

Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas
por: Wu, Rui, et al.
Publicado: (2016)

CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2022)

How I treat older patients with DLBCL in the frontline setting
por: Lugtenburg, Pieternella J., et al.
Publicado: (2023)

Toll-like receptors in the pathogenesis of human B cell malignancies
por: Isaza-Correa, Johana M, et al.
Publicado: (2014)

The Microenvironment in Epstein–Barr Virus-Associated Malignancies
por: Tan, Geok Wee, et al.
Publicado: (2018)

Management of aplastic anemia in a woman during pregnancy: a case report
por: Stibbe, Krista JM, et al.
Publicado: (2011)

A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics
por: Bult, Johanna A. A., et al.
Publicado: (2023)

Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach
por: de Groot, Fleur A., et al.
Publicado: (2022)

T027: High serum levels of Thymus and Activation Related Chemokine (TARC) precede Hodgkin lymphoma diagnosis by several years
por: Diepstra, Arjan, et al.
Publicado: (2022)

Electrolyte disorders secondary to venetoclax
por: van der Lubbe, Nils, et al.
Publicado: (2020)

Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma
por: Jiang, Peijia, et al.
Publicado: (2022)

No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study
por: Geerdes, Emma E., et al.
Publicado: (2023)

Treatment and Survival of Patients With Primary Effusion Lymphoma in the Netherlands: A Population-based Analysis, 2002–2015
por: Dinmohamed, Avinash G., et al.
Publicado: (2018)

Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma
por: Liang, Zheng, et al.
Publicado: (2014)

Soluble PD‐L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2021)

Relapse in stage I(E) diffuse large B‐cell lymphoma
por: Nijland, Marcel, et al.
Publicado: (2017)

Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China
por: Huang, Xin, et al.
Publicado: (2011)

PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV+ Hodgkin Lymphoma
por: Liu, Yuxuan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_21fgurd43feue88ag9017kisfe